Carrier Biomed
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- Undisclosed
Investors
- 4
About Carrier Biomed
, trading as Carrier Biomed operates as a biopharmaceutical company, focusing on exosome technology development and clinical translation. The co-founder as well as the CEO of the company, Zhentao Li, is the member of Special Committee on Research and Application of Extracellular Vesicles of the Chinese Society of Research Hospitals. In 2021, Carrier Biomed was awarded as an outstanding enterprise in the China Innovation and Entrepreneurship Competition. The company has a platform for exosome isolation and multiple pipelines for large-scale multi-center clinical studies, including early blood diagnosis of neurodegenerative diseases, early diagnosis of tumors and dynamic monitoring of late-staged treatments. Tumor pipeline can be used to assist in early screening, differential diagnosis, disease detection, efficacy prediction and prognosis of malignant tumors. Revenue is generated from commercialization of exosome diagnostic products and clinical services for hospitals and research institutions.
Who invested in Carrier Biomed
4 investors across 1 round
See all investors in Carrier Biomed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 28, 2022
Amount
Undisclosed
Investors
Questions about Carrier Biomed
Who invested in Carrier Biomed?
Carrier Biomed has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carrier Biomed raised?
Carrier Biomed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Carrier Biomed last raise money?
Carrier Biomed's most recent round on record is a Series A, in Dec 2022.
What does Carrier Biomed do?
, trading as Carrier Biomed operates as a biopharmaceutical company, focusing on exosome technology development and clinical translation.
Where is Carrier Biomed headquartered?
Carrier Biomed is headquartered in Suzhou, China.
Which VCs invest in companies like Carrier Biomed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Carrier Biomed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Carrier Biomed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.